| |
Lifeline BioTechnologies Expects New Health and Nutritional Supplements to Increase Sales Up to 100%
RENO, Nev.--(BW HealthWire)--Sept. 15, 1998--Lifeline BioTechnologies (OTC BB:LBTI) announced the addition of three new exceptional products to NATURE'S CREATIONS, a wholly-owned subsidiary of Lifeline Biotechnologies, Inc.
These additional products are expected to add millions of dollars to NATURE'S CREATIONS annual revenues, with an expected sales increase of approximately 100%. The current product line is now almost two dozen supplements. The nutritional supplement business is a multi-billion dollar annual market and growing at a double-digit rate.
According to Dr. Kevin Buckman, M.D., Director of Lifeline BioTechnologies, the first of these products is COLLAGEN 2, representing a major breakthrough in aiding in the treatment of arthritis. Studies completed at Harvard Medical, by Dr. John Gutierrez and Dr. Alex Duarte have shown marked effectiveness in the treatment of all forms of arthritis. In addition COLLAGEN 2 has shown to be very effective in back pain as well as knee injuries and joint pain.
The second product known as OLYMP'C GOLD(TM), a proprietary formula, provides muscle strength and energy for daily activity and sports. This patent pending formula provides an effective supplement and is being sold for young and old alike.
The third product known as ANTIOX(TM) provides superior antioxidant protection. Experts in this field have written and published articles about its unique qualities and numerous medical benefits. It is the only intracellular (works within the cells of the body) and extracellular (works outside of the cells of the body) in the tissue, blood and body fluids. It provides protection from excessive, body-damaging, free-radicals that we are exposed to.
Lifeline BioTechnologies, Inc.'s (Lifeline) has developed a non-invasive test for early breast cancer detection. The test is incorporated into a proprietary product called First Warning(TM). In preliminary pilot studies, First Warning(TM) demonstrated great promise in detecting formation of extremely early stage breast lesions, particularly in younger women.
The second product division under Lifeline BioTechnologies is a line of nutritional food supplements packaged and sold under the tradename NATURE'S CREATIONS. These supplements are marketed and directed towards people afflicted with degenerative diseases that are commonly found in the aging population. These diseases include cancer (breast, colon and prostate) cardiovascular, osteoporosis and mental alertness.
For more information, contact Dr. Kevin Buckman at 702/852-3222 or fax 702/852-7551.
Financial Statements in this press release (if any) other than historical facts are ''forward-looking'' statements with the meaning of section 27A of the Securities Act of 1933, section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.
|
|
